Shimizu et al. (2017) found that deletion of Rock2 reduced expression of connective tissue growth factor (CTGF), α-SMA and FGF2, which attenuated cardiac hypertrophy and fibrosis. Our sequencing results indicate that Rock1 and Rock2 were both decreased by FGF2. The gene discussed is FGF2; the disease is cardiac hypertrophy.